| Net Cash Provided by (Used in) Operating Activities |
$204,706 |
USD |
-26% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$2,416,262 |
USD |
84% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$2,630,403 |
USD |
-83% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
100,000,000 |
shares |
0% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares, Issued |
4,061,166 |
shares |
-26% |
Q1 2025 |
Q1 2025 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$19,189 |
USD |
-95% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$887,122 |
USD |
118% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
$887,122 |
USD |
118% |
Q4 2024 |
FY 2024 |
| Deferred Income Tax Expense (Benefit) |
$0 |
USD |
|
Q1 2024 |
Q1 2024 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q1 2025 |
Q1 2025 |
| Preferred Stock, Shares Authorized |
1,000,000 |
shares |
0% |
Q1 2025 |
Q1 2025 |
| Unrecognized Tax Benefits |
$0 |
USD |
|
Q4 2024 |
FY 2024 |
| Additional Paid in Capital |
$0 |
USD |
|
Q1 2025 |
Q1 2025 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$0 |
USD |
|
Q4 2024 |
FY 2024 |
| Preferred Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q1 2025 |
Q1 2025 |